Central Bank & Trust CO Abiomed Inc Transaction History

Central Bank & Trust CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 15, 2020	SELL	$141.4 - $257.09 $895,627 - $1.63 Million	-6,334 Closed	0 $0
Q1 2020 Apr 14, 2020	BUY	$130.51 - $196.01 $826,650 - $1.24 Million	6,334 New	6,334 $1.65 Million
Q4 2019 Jan 13, 2020	SELL	$159.31 - $223.54 $1.18 Million - $1.66 Million	-7,427 Closed	0 $0
Q3 2019 Oct 23, 2019	BUY	$175.89 - $279.23 $192,247 - $305,198	1,093 Added 17.26%	7,427 $1.32 Million
Q2 2019 Jul 16, 2019	BUY	$250.96 - $284.94 $1.34 Million - $1.52 Million	5,323 Added 526.51%	6,334 $1.65 Million
Q1 2019 Apr 22, 2019	BUY	$276.39 - $362.25 $213,925 - $280,381	774 Added 326.58%	1,011 $289,000
Q4 2018 Jan 17, 2019	SELL	$281.08 - $444.25 $384,517 - $607,734	-1,368 Reduced 85.23%	237 $77,000
Q3 2018 Nov 23, 2018	BUY	$354.53 - $449.75 $569,020 - $721,848	1,605 New	1,605 $722,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Central Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Bank & Trust CO with notifications on news.